Eye Care-Focused Biopharma Firm SpyGlass Files for US IPO
SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such...
By Avalon Pernell, Anthony Hughes · Bloomberg
SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such as glaucoma.